Effects of kaempferol on the mechanisms of drug resistance in the human glioblastoma cell line T98G

Pharmazie

Volumn 65, Issue 5, 2010, Pages 378-382

  Nakatsuma, Akira ^a   Fukami, T ^b   Suzuki, T ^b   Furuishi, T ^b   Tomono, K ^b   Hidaka, S ^b  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCEIN; CISPLATIN; DOXORUBICIN; GLUTATHIONE; GLUTATHIONE TRANSFERASE; KAEMPFEROL; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; FOOD; GLIOBLASTOMA; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MULTIDRUG RESISTANCE;

EID: 77953070882     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.9807     Document Type: Article

References (32)

1. Abe T, Hasegawa S, Taniguchi K, Yokomizo A, Kuwano T, Ono M, Mori T, Hori S, Kohno K, Kuwano M (1994) Possible involvement of multidrugresistance- associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells. Int J Cancer 58: 860-864. (Pubitemid 24306377)
2. Arjmandi BH, Lucas EA, Khalil DA, Devareddy L, Smith BJ, McDonald J, Arquitt AB, Payton ME, Mason C (2005) One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women. Nutr J 4: 8. (Pubitemid 40594714)
3. Asmis R, Wang Y, Xu L, Kisgati M, Begley JG, Mieyal JJ (2005) A novel thiol oxidation-based mechanism for adriamycin-induced cell injury in human macrophages. FASEB J 19: 1866-1868. (Pubitemid 41598777)
4. Borst P, Evers R, Kool M,Wijnholds J (2000) A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 92: 1295-1302. (Pubitemid 30662093)
5. Bray BJ, Perry NB, Menkes DB, Rosengren RJ (2002) St. John'swort extract induces CYP3A and CYP2E1 in the Swiss Webster mouse. Toxcol Sci 66: 27-33.
6. Conrad S, Kauffmann HM, Ito K, Leslie EM, Deeley RG, Schrenk D, Cole SP (2002) A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance. Pharmacogenetics 12: 321-330. (Pubitemid 34620660)
7. Depeille P, Cuq P, Mary S, Passagne I, Evrard A, Cupissol D, Vian L (2004) Glutathione S-transferase M1 and multidrug resistance protein 1 act in synergy to protect melanoma cells from vincristine effects. Mol Pharmacol 65: 897-905. (Pubitemid 38420495)
8. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A 95: 15665-15670. (Pubitemid 29018757)
9. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CY (2002) Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther 72: 276-287.
10. Ha HR, Chen J, Leuenberger PM, Freiburghaus AU, Follath F (1995) In vitro inhibition of midazolam and quinidine metabolism by flavonoids. Eur J Clin Pharmacol 48: 367-371.
11. Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139.
12. Hayeshi R, Mutingwende I, Mavengere W, Masiyanise V, Mukanganyama S (2007) The inhibition of human glutathione S-transferases activity by plant polyphenolic compounds ellagic acid and curcumin. Food Chem Toxicol 45: 286-295. (Pubitemid 44854313)
13. Leslie EM, Mao Q, Oleschuk CJ, Deeley RG, Cole SP (2001) Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids. Mol Pharmacol 59: 1171-1180. (Pubitemid 32381597)
14. Limtrakul P, Anuchapreeda S, Buddhasukh D (2004) Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids.BMC Cancer 4: 13.
15. Litman T, Brangi M, Hudson E, Fetsch P, Abati A, Ross DD, Miyake K, Resau JH, Bates SE (2000) The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). Cell Sci 113: 2011-2021. (Pubitemid 30386505)
16. McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P (2007) The Hawthorne Effect: a randomised, controlled trial. BMC Med Res Methodol 7: 30. (Pubitemid 47203063)
17. Marchetti S, Mazzanti R, Beijnen JH, Schellens JH (2007) Concise review: clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein). Oncologist 12: 927-941. (Pubitemid 47359135)
18. Matsumoto Y, Tamiya T, Nagao S (2005) Resistance to topoisomerase II inhibitors in human glioma cell lines overexpressing multidrug resistant associated protein (MRP) 2. J Med Invest 52: 41-48. (Pubitemid 40502567)
19. Naasani I, Oh-Hashi F, Oh-Hara T, Feng WY, Johnston J, Chan K, Tsuruo T (2003) Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res 63: 824-830. (Pubitemid 36231983)
20. Nieri P, Romiti N, Adinolfi B, Chicca A, Massarelli I, Chieli E (2006) Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells. Br J Pharmacol 148: 682-687. (Pubitemid 43993058)
21. Ogura R, Sugiyama M, Haramaki N, Hidaka T (1991) Electron spin resonance studies on the mechanism of adriamycin-induced heart mitochondrial damages. Cancer Res 51: 3555-3558.
22. Ohnishi A, Matsuo H, Yamada S, Takanaga H, Morimoto S, Shoyama Y, Ohtani H, Sawada Y (2000) Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4. Br J Pharmacol 130: 1369-1377. (Pubitemid 30488602)
23. Park CH, Chang JY, Hahm ER, Park S, Kim HK, Yang CH (2005) Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun 328: 227-234. (Pubitemid 40164659)
24. Perloff MD, von Moltke LL, Störmer E, Shader RI, Greenblatt DJ (2001) Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. Br J Pharmacol 134: 1601-1608. (Pubitemid 34038092)
25. Schubert W, Eriksson U, Edgar B, Cullberg G, Hedner T (1995) Flavonoids in grapefruit juice inhibit the in vitro hepatic metabolism of 17 beta-estradiol. Eur J Drug Metab Pharmacokinet 20: 219-224.
26. Schutte ME, Freidig AP, van de Sandt JJ, Alink GM, Rietjens IM, Groten JP (2006) An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers. Toxicol Appl Pharmacol 217: 204-215.
27. Sharma V, Joseph C, Ghosh S, Agarwal A, Mishra MK, Sen E (2007) Kaempferol induces apoptosis in glioblastoma cells through oxidative stress. Mol Cancer Ther 6: 2544-2553. (Pubitemid 47480420)
28. Takanaga H, Ohnishi A, Matsuo H, Sawada Y (1998) Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in Caco-2 cells. Biol Pharm Bull 21: 1062-1066. (Pubitemid 28513983)
29. Uesawa Y, Mohri K (2006) The use of heat treatment to eliminate drug interactions due to grapefruit juice. Biol Pharm Bull 29: 2274-2278. (Pubitemid 44690956)
30. van Zanden JJ, Geraets L, Wortelboer HM, van Bladeren PJ, Rietjens IM, Cnubben NH (2004) Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. Biochem Pharmacol 67: 1607-1617. (Pubitemid 38388223)
31. van Zanden JJ, Wortelboer HM, Bijlsma S, Punt A, Usta M, Bladeren PJ, Rietjens IM, Cnubben NH (2005) Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. Biochem Pharmacol 69: 699-708.
32. Zaman GJ, Lankelma J, van Tellingen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RP, Baas F, Borst P (1995) Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci U S A 92: 7690-7694.